Of the 35 affected health zones, the outbreak remains active in 28 health zones that have reported cases in the past 21 days.
The remaining seven health zones have not reported any new cases during this period.
These include Gety (38 days), Mambasa (26 days), Rimba (25 days), and Aru (24 days) in Ituri Province; Kalunguta (35 days) and Goma (34 days) in North Kivu Province; and Miti-Murhesa (39 days) in South Kivu Province.
Among the 28 health zones that have reported 709 confirmed cases, including 262 confirmed deaths in the past 21 days, transmission remains heavily concentrated in Ituri Province, which accounts for 89.4% of reported cases (634 cases) and 86.3% of deaths (226 deaths) during this period.
Most cases reported during this period were from Bunia (181), Rwampara (173), Mongbwalu (144), Nyankunde (62), and Nizi (34) in Ituri Province, as well as Butembo (27) and Katwa (26) in North Kivu Province.
Together, these health zones account for 91.3% of all confirmed cases reported nationally over the past 21 days.
No new confirmed case has been reported from South Kivu since 26 May 2026.
Deaths reported during the same period were also concentrated in a limited number of health zones, particularly Mongbwalu (81), Bunia (59), Rwampara (36), Katwa (15), Nyankunde (12), Mangala (12),and Butembo (10).
Together, these health zones account for 85.9% of all deaths reported nationally in the past 21 days.
Cumulatively, a total of 1307 confirmed cases, including 377 confirmed deaths [case fatality ratio (CFR) 28.8%], have been reported in the Democratic Republic of the Congo since the start of the outbreak.
Ituri Province remains the most affected, accounting for 91.6% (1197) of all confirmed cases and 84.4% (318) of all reported deaths nationwide.
The most affected health zones are Bunia (344 cases, 74 deaths), Rwampara (295 cases, 56 deaths), Mongbwalu (258 cases, 121 deaths), Nyankunde (94 cases, 13 deaths), and Nizi (39 cases, 9 deaths), all located in Ituri Province, as well as Katwa (38 cases, 23 deaths) and Butembo (33 cases, 14 deaths) in North Kivu Province. Together, these seven health zones account for 84.2% of cumulative confirmed cases and 82.2% of confirmed deaths reported nationally.
The CFR remains highest in North Kivu Province at 54.2% (58 deaths/107 cases), followed by South Kivu at 33.3% (1/3), and Ituri at 26.6% (318/1197), indicating persistently higher mortality among reported cases in North Kivu.
The geographic distribution of recent transmission largely mirrors the cumulative outbreak pattern, with sustained concentration in Ituri Province and continued high mortality reported from a limited number of health zones.
(...)
As of 28 June 2026, a total of 9968 contacts were under follow-up across affected provinces in the Democratic Republic of the Congo, of whom 8105 (81.3%) were successfully seen in the past 24 hours.
Ituri accounted for the largest number of contacts under follow-up, with 7706 contacts, of whom 6319 (82.9%) were reached.
In North Kivu, 2244 of 1696 contacts (75.6%) were seen, while all 18 identified contacts in South Kivu were followed up, corresponding to a 100% follow-up rate.
Despite recent improvements, contact follow-up coverage remains suboptimal overall, leaving a significant proportion of contacts not reached and increasing the risk of missed infections and ongoing transmission.
(...)
Uganda
No new case has been reported from Uganda since the last update. The most recent case, reported on 21 June 2026, involved a truck driver operating along the Democratic Republic of the Congo–Uganda international route. The case developed symptoms on 15 June 2026, entered Uganda on 19 June 2026, and was isolated on 20 June 2026 at the Mulago Ebola Treatment Unit.
As of 28 June 2026, a cumulative total of 21 cases (20 confirmed and one probable), including three deaths (two confirmed and one probable), had been reported in the Kampala.
A total of 15 patients have recovered and been discharged, while three remain admitted for care.
Of the 831 contacts identified since the start of the outbreak, five remained under follow-up as of 28 June 2026.
{Click on Image to Enlarge}
France
On 24 June 2026, French authorities notified WHO of a laboratory-confirmed case of Ebola disease caused by Bundibugyo virus in a middle-aged male physician returning from the Democratic Republic of the Congo.
The patient had been deployed for five weeks in Ituri Province, where he was involved in the care of patients with BVD.
Upon arrival at Charles de Gaulle Airport on 23 June 2026, the patient self-reported symptoms to airport health authorities, prompting immediate isolation and referral to a designated high-containment healthcare facility.
At the time of reporting, the patient was clinically stable and apyretic, with no reported vomiting, diarrhoea, or haemorrhagic manifestations during travel.
PCR testing detected Bundibugyo virus. Comprehensive contact tracing has been initiated.
Risk Assessment
The overall risk remains very high in the Democratic Republic of the Congo, with transmission continuing at a scale that exceeds current response capacity, particularly in the Bunia–Rwampara–Mongbwalu corridor and across other affected health zones.
North Kivu’s markedly higher CFR points to possible delays in diagnosis and access to care, while clinical capacity in Ituri is approaching saturation.
Although contact follow-up and alert investigation have improved, performance remains insufficient to rapidly interrupt transmission.
Uganda remains exposed through sustained population movement from eastern Democratic Republic of the Congo, including trucking routes and possible informal cross-border movement linked to border closures.
The imported case reported in France further confirms that international exportation risk persists, requiring strengthened surveillance, traveller awareness, and cross-border coordination
(...)
Situation interpretation
The BVD outbreak continues to expand at a pace that exceeds current response capacity, with sustained high-intensity transmission ongoing in several hotspot areas.
Although important operational gains have been achieved, including improved contact follow-up, expanded decentralized laboratory capacity, increased treatment capacity, and strengthened cross-border coordination, overall response performance remains below the level required to rapidly interrupt transmission.
The continued increase in cases and deaths, near-saturation of treatment facilities, and suboptimal IPC readiness in health facilities underscore the need for a stronger operational surge focused on hotspot containment, rapid case detection and isolation, expansion of decentralized clinical and laboratory services, enhanced community engagement, and strengthened cross-border surveillance.
The imported case reported in France further highlights the continuing risk of international spread and reinforces the need for sustained regional and international mobilization, including rapid operationalization of pledged resources and intensified support to frontline response activities.
No comments:
Post a Comment